News & Updates

The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, results in a reduced risk of autoimmune rheumatic disease among adults with type 2 diabetes (T2D), reports a recent study.

Patients with rheumatoid arthritis (RA) who are positive for both anticyclic citrullinated peptide antibody (ACPA) and rheumatoid factor (RF) have lower remission rate, higher baseline erythrocyte sedimentation rate (ESR), and need more corticosteroid and disease-modifying antirheumatic drugs (DMARDs) than those with single positivity or double negativity, according to a Singapore study.